PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33548240-2 2021 Meanwhile, AMPD promotes the formation of substrates of xanthine oxidoreductase (XOR), which produces ROS as a byproduct. ros 102-105 xanthine dehydrogenase Rattus norvegicus 56-79 33548240-2 2021 Meanwhile, AMPD promotes the formation of substrates of xanthine oxidoreductase (XOR), which produces ROS as a byproduct. ros 102-105 xanthine dehydrogenase Rattus norvegicus 81-84 33548240-10 2021 Inhibition of XOR suppressed the production of tissue ROS and mitochondrial dysfunction and improved ventricular function under the condition of pressure overload in OLETF. ros 54-57 xanthine dehydrogenase Rattus norvegicus 14-17 33548240-11 2021 CONCLUSIONS: The results suggest that increases in the activity of XOR and the formation of XOR substrates by upregulated AMPD contribute to ROS-mediated diastolic ventricular dysfunction at the time of increased cardiac workload in diabetic hearts. ros 141-144 xanthine dehydrogenase Rattus norvegicus 67-70 33548240-11 2021 CONCLUSIONS: The results suggest that increases in the activity of XOR and the formation of XOR substrates by upregulated AMPD contribute to ROS-mediated diastolic ventricular dysfunction at the time of increased cardiac workload in diabetic hearts. ros 141-144 xanthine dehydrogenase Rattus norvegicus 92-95 33132325-1 2020 Xanthine and hypoxanthine are intermediate metabolites of uric acid and a source of reactive oxidative species (ROS) by xanthine oxidoreductase (XOR), suggesting that facilitating their elimination is beneficial. ros 112-115 xanthine dehydrogenase Rattus norvegicus 145-148 33132325-10 2020 Accordingly, it is expected that treatment with XOR and URAT1 inhibitors will effectively decrease purine pools in the body and prevent cell injury due to ROS generated during XOR-mediated reactions. ros 155-158 xanthine dehydrogenase Rattus norvegicus 48-51 33132325-10 2020 Accordingly, it is expected that treatment with XOR and URAT1 inhibitors will effectively decrease purine pools in the body and prevent cell injury due to ROS generated during XOR-mediated reactions. ros 155-158 xanthine dehydrogenase Rattus norvegicus 176-179